IP Verse

Regeneron Pharmaceuticals Inc. vs. Amgen Inc.

Case Details

Case Number:CC_586764/2023
Patent Number:EP3666797
Case Filing Date:10 Nov, 2023
Proceeding Type:Proceeding
Action/Application:Counterclaim For Revocation
Decision Date:16 Jul, 2024
Court Division:First Instance, Central Division - Munich
Language of Proceeding:English
Plaintiffs:

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Judges:

Andras Kupecz

Casper Struve

Ulrike Voß

Case Decision

Decision Date:16 Jul, 2024
Decision Documents:

More cases on EP3666797B1

Case Number:ACT_459916/2023
Plaintiffs:

Amgen Inc.

Defendants:

Regeneron Pharmaceuticals Inc.

Sanofi-Aventis Groupe S.A.

Sanofi Winthrop Industrie S.A.

Sanofi-Aventis Deutschland Gmbh

Case Number:ACT_459505/2023
Plaintiffs:

Sanofi-Aventis Deutschland Gmbh

Sanofi Winthrop Industrie S.A.

Sanofi-Aventis Groupe

Defendants:

Amgen

More cases on Regeneron Pharmaceuticals Inc.

Case Number:APL_572929/2023
Plaintiffs:

Sanofi-Aventis Groupe S.A.

Regeneron Pharmaceuticals Inc.

Sanofi Winthrop Industrie S.A.

Sanofi-Aventis Deutschland Gmbh

Defendants:

Amgen Inc.

Case Number:ACT_597355/2023
Plaintiffs:

Sanofi Biotechnologies Sas

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Amgen Gmbh

Amgen Europe B.V.

Amgen Nv

Amgen S.R.L.

Amgen B.V.

Amgen S.A.S.

More cases on Amgen Inc.

Case Number:APL_572929/2023
Plaintiffs:

Sanofi-Aventis Groupe S.A.

Regeneron Pharmaceuticals Inc.

Sanofi Winthrop Industrie S.A.

Sanofi-Aventis Deutschland Gmbh

Defendants:

Amgen Inc.

Case Number:ACT_597355/2023
Plaintiffs:

Sanofi Biotechnologies Sas

Regeneron Pharmaceuticals Inc.

Defendants:

Amgen Inc.

Amgen Gmbh

Amgen Europe B.V.

Amgen Nv

Amgen S.R.L.

Amgen B.V.

Amgen S.A.S.